STAT

JULY 31, 2023

Years later, while working as a physician in Massachusetts, I was appalled to observe how many medicines failed to benefit society’s most vulnerable, in particular people of color. Our family doctor, a leading figure in the community, inspired me to follow in his footsteps and help people in need.

94

94

STAT

OCTOBER 23, 2023

MADRID — Results presented Monday could expand the use of a Novartis therapy for metastatic prostate cancer, moving it from a treatment used after chemotherapy to one with demonstrated benefits beforehand as well.

Chemotherapy 104

Chemotherapy 104

STAT

JUNE 3, 2023

“Twinning programs” helped to reduce survival disparities in childhood acute leukemia between high income and lower income countries, according to a study presented here at the American Society of Clinical Oncology on Saturday. Read the rest…

Hospitals 92

Hospitals 92

STAT

AUGUST 25, 2023

Just weeks after Novo Nordisk announced that its obesity drug Wegovy cut the risk of heart complications in a major trial, the company now has results from a different study showing the treatment can also benefit people with a common type of heart failure. Continue to STAT+ to read the full story…

96

96

STAT

DECEMBER 21, 2022

An influential board of infectious disease physicians recommended Wednesday that hospitals and other health care facilities stop routinely screening asymptomatic patients for Covid-19, saying the potential risks of screenings now outweigh the benefits.

Hospitals 100

Hospitals 100

STAT

APRIL 12, 2023

Last fall in STAT, Matt Herper questioned whether the biomedical research enterprise is really laying the necessary groundwork to gain the full benefit of innovation in “biology’s century.”

106

106

IDStewardship

AUGUST 1, 2023

Pharmacists provide significant benefits in PK/PD with the knowledge they have learned and transferred to clinical practice during bachelor and postgraduate education. Similarly, the societies in our country have begun to devote more space to this issue. I believe that more concrete and strong steps can be taken hereafter.

Hospitals 212

Hospitals Community Pharmacies Dosage Communication 212

STAT

MARCH 8, 2023

I’ve seen the benefits of teletherapy firsthand. As society has reopened, we’ve continued to hear countless stories where patients have been able to get much-needed care that was simply not available physically near their home or place of work.

Insurance 103

Insurance 103

Hospital Pharmacy Europe

DECEMBER 18, 2023

To this end, the Society of Geriatric Oncology and the French Society of Oncology Pharmacists have published a position paper to support this collaboration. As these patients are often treated with multiple medications, the benefit–risk ratios should be regularly reassessed.

Chemotherapy 96

Chemotherapy Hospitals Labelling Communication 96

Pharmaceutical Technology

APRIL 3, 2023

An innovative drug specifically designed to treat liver cancer can greatly improve treatment outcome and bring huge clinical benefits to patients.” Ablaze Pharmaceuticals president and CEO Dr Alex Qiao said: “Liver cancer therapy is a significant unmet medical need in China, and existing treatment options are very limited and ineffective. “An

Hospitals 98

Hospitals 98

European Pharmaceutical Review

DECEMBER 11, 2023

The data was presented at the European Society for Medical Oncology (ESMO) and Society of Gynecologic Oncology (SGO) Annual Meeting in March 2023, and published in the New England Journal of Medicine.

Chemotherapy 85

Chemotherapy 85

Hospital Pharmacy Europe

MARCH 7, 2024

Many oncology drugs approved by the European Medicines Agency (EMA) between 2005 and 2020 provide ‘little or no added benefit’ for patients, according to new research. Many drugs with higher benefit ratings were associated with more significant revenues for the associated pharmaceutical companies, they added.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Hospitals 52

The FDA Law Blog

MAY 1, 2024

Her background also includes significant roles such as serving as an adjunct professor at the George Washington University Law School, where she coaches health law moot court teams, and engaging actively with key industry groups like the Society for Clinical Research Associates and the Food and Drug Law Institute.

FDA 52

FDA 52

BioPharm

OCTOBER 8, 2023

Regardless of the sector, the goal remains the same – benefiting society through the creation of pharmaceutical, diagnostic, agricultural, environmental, and other products that utilize living cells and cellular materials. The biotechnology industry is both vast and complex, with sectors varying from agricultural to pharmaceutical.

40

40

STAT

NOVEMBER 16, 2022

Yet their contributions — and sacrifices — lead to important medical discoveries that benefit society as a whole. That’s what our new analysis of health care investing shows. In the second decade of the 21st century, investors with low appetite for risk were satisfied with 1% interest yields from U.S.

Pharmaceutical Companies 85

Pharmaceutical Companies Pharmaceutical Companies 85

European Pharmaceutical Review

MARCH 8, 2024

As for its benefits in pharmacovigilance, the paper explained that GAMP 5 “helps organisations maintain high-quality standards in adverse event reporting and analysis, ensuring the safety of patients and the integrity of data. GAMP 5 update: computerized system expectations for pharma manufacturers Benefits of Pharma 4.0

82

82

European Pharmaceutical Review

APRIL 5, 2024

These interim data indicate early signs of potential clinical benefit with mRNA-3927, and importantly also demonstrate that mRNA-3927 has infrequent treatment-limiting side effects. Study data was presented at the 2023 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting.

Vaccines 88

Vaccines 88

STAT

MARCH 21, 2023

Then, from 2007 , there was new attention paid to dual use research, or experiments that could both benefit and harm society, agriculture, or the environment. Read the rest…

96

96

Hospital Pharmacy Europe

OCTOBER 2, 2023

This warning comes from the Royal Pharmaceutical Society (RPS) as it launches a new checklist for pharmacists to help inform conversations with patients about penicillin allergy and diagnose if a patient is allergic to penicillin or not.

Medical Records 105

Medical Records Labelling Hospitals 105

European Pharmaceutical Review

MAY 7, 2024

Moreover, initial study findings were featured at the European Society for Medical Oncology 2023 Congress. The post Intravesical drug delivery system exhibits bladder cancer benefit appeared first on European Pharmaceutical Review. Interim results were presented at the European Association of Urology (EAU) 2024 Annual Congress.

Hospitals 76

Hospitals FDA 76

European Pharmaceutical Review

SEPTEMBER 15, 2022

According to Novartis, Kisqali ® (ribociclib) plus endocrine therapy in the first-line setting added nearly a year of additional overall survival (OS) benefit in a subgroup of patients with aggressive forms of hormone receptor-positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced breast cancer (aBC).

80

80

STAT

DECEMBER 13, 2023

employers facing surging costs from paying for Novo Nordisk’s Wegovy and similar obesity drugs are hiring virtual health care providers like Teladoc to implement weight-loss management programs , according to Reuters , which spoke with a dozen consultants, pharmacy benefit managers, analysts, and health care providers. These

Hospitals 95

Hospitals 95

pharmaphorum

MARCH 15, 2022

The COVID-19 pandemic has radically disrupted traditional medical society conferences in a way that could scarcely have been imagined in 2019. The vast majority of societies were able to transition their planned physical events to virtual formats within remarkably short periods of time, and some delivered impressive attendee experiences.

Labelling 105

Labelling Vaccines Communication 105

Hospital Pharmacy Europe

JANUARY 16, 2024

Meanwhile, the Royal Pharmaceutical Society, which hosts PRUK’s offices and staff, has announced the appointment of Dr Amira Guirguis as the new chair of its Science and Research Committee (SRC). From 2024, all UK registered pharmacists and pharmacy technicians are eligible to apply to the PRUK research grant schemes.

Hospitals 105

Hospitals Patient Care 105

Hospital Pharmacy Europe

JULY 18, 2023

Commenting on the research, Dr Richard Oakley, associate director of research and innovation at the Alzheimer’s Society, said:  ‘This is truly a turning point in the fight against Alzheimer’s and science is proving that it is possible to slow down the disease. of people receiving the drug. of people receiving the drug.

Hospitals 98

Hospitals 98

European Pharmaceutical Review

JUNE 6, 2023

These results were presented in an abstract at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting. The adjuvant treatment was given to early-stage (IB, II and IIIA) epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer ( NSCLC ) patients following a complete tumour resection with curative intent.

91

91

European Pharmaceutical Review

APRIL 15, 2024

Positive data from MaaT Pharma’s Microbiome Ecosystem Therapy TM (MET) MaaT013 as a treatment for acute graft-versus-host disease (aGvHD), is set to be presented at the 2024 European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting.

Hospitals 87

Hospitals 87

Hospital Pharmacy Europe

JUNE 9, 2023

However, whether this combination would benefit women with early stage breast cancer remains unclear. The abstract also reported how this iDFS benefit was generally consistent across stratification factors and other subgroups. In addition, the three-year iDFS rates were rates were 90.4% respectively.

Dosage 98

Dosage Labelling Hospitals 98

Roots Analysis

FEBRUARY 27, 2024

The immense benefits offered by CRISPR makes it one of the most preferred genome editing approach. The global genome editing market is anticipated to grow at a CAGR of 12.6% during the forecast period 2023-2035.

40

40

European Pharmaceutical Review

JANUARY 30, 2024

Results from a Phase III, randomised, placebo-controlled clinical trial have for the first time in fifty years, demonstrated an overall survival benefit from an adjuvant therapy in kidney cancer. Findings from the study were presented at the American Society of Clinical Oncology (ASCO) Genitourinary Cancer Symposium in January 2024.

Immunization 88

Immunization 88

Pharmaceutical Technology

JUNE 4, 2023

At the ongoing American Society of Clinical Oncology (ASCO) Annual Meeting, being held 2–6 June, new data was presented from the randomized, controlled Phase III KEYNOTE-671 study of MSD’s Keytruda (pembrolizumab) (abstract LBA100). The median overall survival was not reached in the Keytruda arm and was 45.5 in the Keytruda arm, and 5.3%

Chemotherapy 75

Chemotherapy Hospitals FDA 75

PharmaShots

JUNE 28, 2023

Potential Benefits of Integrating Health Tech into Life Insurance Incorporating health tech into life insurance practices has the potential to yield far-reaching benefits for all involved parties, redefining the relationships and processes within the industry. This allows for early intervention and potentially better health outcomes.

Insurance 40

Insurance 40

Hospital Pharmacy Europe

NOVEMBER 2, 2023

The Royal Pharmaceutical Society (RPS) is seeking feedback from hospital pharmacists on its green guide to making professional pharmacy practice more environmentally sustainable. The online consultation will run until 8 November 2023.

Hospitals 52

Hospitals Community Pharmacies Documentation Communication 52

European Pharmaceutical Review

DECEMBER 15, 2023

The companies previously presented data from KEYNOTE-942/mRNA-4157-P201, with a follow-up of approximately two years, at the American Association for Cancer Research (AACR) Annual Meeting, and the American Society of Clinical Oncology (ASCO) Annual Meeting.

Vaccines 96

Vaccines Research Laboratories Immunization 96

pharmaphorum

JANUARY 22, 2021

In a statement, the MS Society said it was “frustrating” that NICE had decided not to recommend funding for Zeposia. Along with other technical data, NICE said it wanted to see data comparative with other second line treatments such as Lemtrada and Gilenya.

98

98

The Checkup by Singlecare

JANUARY 22, 2024

While some research suggests that “there’s a small increase in good cholesterol (HDL) levels with alcohol consumption, the minuscule cholesterol benefit is not enough to overcome the negative effects on liver and brain health,” says Sanjay Bhojraj, MD , an interventional cardiologist at Providence in Orange County, California, and founder of Well12.Health.

111

111

Hospital Pharmacy Europe

MAY 30, 2023

Benefits from lipid reductions To get a better understanding of the impact of these reductions, it is worth putting the changes into context. A previous analysis of the benefits from lipid reductions indicated that for every 1 mmol/L decrease in TC, there was a 17.5% for any CHD-related event. Using TC as an example, a 0.34

Hospitals 52

Hospitals 52